Abstract
Noninvasive positron emission tomography (PET)-based studies of myocardial blood flow and substrate metabolism characterized the human heart as an organ fully integrated with the general function of the human body. Cardiac energy demands are tightly coupled to peripheral needs in oxygen and, in turn, govern changes in myocardial blood flow and substrate supply. Substrate selection and utilization depend largely on substrate availability and, hence, on concentrations of fuel substrate in blood. Endocrine and neuronal factors together with regional transport processes modulate and fine tune regional rates of substrate utilization. Manipulation of substrate availability as for example through dietary or pharmacologic maneuvers offer a means to probe regional substrate interactions, to demonstrate shifts in substrate selection between free fatty acid and glucose and, hence, to confirm the operation of regulatory mechanisms established previously in animal experiments. In abnormal states, local factors modulate the generally integrated responses and synchronize regional substrate utilization and metabolism with regional needs. Diminished substrate delivery in chronic low flow conditions is matched by a down regulation in regional contractile function possibly as an energy saving measure, together with a decline in oxidative metabolism as evidenced by reduced oxidation of 11C-palmitate and delayed turnover of 11C-acetate. Activation of rate controlling enzymes together with enhanced transmembraneous transport systems represent flux generating steps for enhanced regional glucose consumption possibly as a means for reducing oxygen needs and at the same time, preserving cellular homeostasis. PET identifies such regional metabolic adjustments as regional increases in 18F-deoxyglucose uptake as a clinically useful hallmark of myocardial viability. Regional glucose utilization in this case no longer fully responds to general control mechanisms of substrate selection but is modified by local factors or, ultimately may become part of a local microsystem as a means of protection against potentially deleterious consequences of disease. © 2000 Biomedical Engineering Society.
PAC00: 8758Fg, 8719Hh, 8719Uv, 8716Uv, 8715Rn
Similar content being viewed by others
References
Araujo, L., A. Lammertsma, C. Rhodes, E. McFalls, H. Iida, E. Rechavia, A. Galassi, R. De Silva, T. Jones, and A. Ma-seri. Noninvasive quantification of regional myocardial blood flow in coronary artery disease with oxygen-15-labeled car-bon dioxide inhalation and positron emission tomography. Circulation 83:875–885, 1991.
Ausma, J., F. Thonae, G. D. Dispersyn, W. Flameng, J. L. Vanoverschelde, F. C. Ramaekers, and M. Borgers. Dediffer-entiated cardiomyocytes from chronic hibernating myocar-dium are ischemiatolerant. Mol. Cell. Biochem. 186:159–168, 1998.
Ballard, F., W. Danforth, S. Nagele, and R. Bing. Myocardial metabolism of fatty acids. J. Clin. Invest. 39:717–723, 1960.
Beanlands, R. S., P. J. Hendry, R. G. Masters, R. A. de-Kemp, K. Woodend, and T. D. Ruddy. Delay in revascular-ization is associated with increased mortality rate in patients with severe left ventricular dysfunction and viable myocar-dium on fluorine 18-fluorodeoxyglucose positron emission tomography imaging. Circulation 98:II51–II56, 1998.
Bergmann, S., M. Shelton, C. Weinheimer, and P. Herrero. Accuracy of quantitative estimates of myocardial blood flow with rubidium-82 and positron emission tomography. J. Nucl. Med. 30:807, 1989.
Bing, R. J. The metabolism of the heart. Harvey Lectures:27–70, 1954/1955.
Brown, M. A., D. W. Myears, and S. R. Bergmann. Validity of estimates of myocardial oxidative metabolism with carbon-11 acetate and positron emission tomography despite altered patterns of substrate utilization. J. Nucl. Med. 30:187–193, 1989.
Chen, C., M. Lijie, D. Linfert, T. Lai, J. Fallon, L. Gillam, D. Waters, and G. Tsongalis. Myocardial cell death and apop-tosis in hibernating myocardium. J. Am. Coll. Cardiol. 30:1407–1412, 1997.
Czernin, J., P. Mu¨ ller, S. Chan, R. Brunken, G. Porenta, J. Krivokapich, K. Chen, A. Chan, M. Phelps, and H. Schelbert. Influence of age and hemodynamics on myocardial blood flow and flow reserve. Circulation 88:62–69, 1993.
Czernin, J., and H. R. Schelbert. Non-invasive quantification of myocardial blood flow and flow reserve using dynamic positron emission tomography. Wiener Klinische Wochen-schrift 106:478–486, 1994.
Depre´, C., J.-L. J. Vanoverschelde, J. Melin, M. Borgers, A. Bol, J. Ausma, R. Dion, and W. Wijns. Structural and meta-bolic correlates of the reversibility of chronic left ventricular ischemic dysfunction in humans. Am. J. Physiol. 268:H1265–H1275, 1995.
Elsa¨sser, A., M. Schlepper, W. P. Kleovekorn, W. J. Cai, R. Zimmermann, K. D. Meuller, R. Strasser, S. Kostin, C. Ga-gel, B. Meunkel, W. Schaper, and J. Schaper. Hibernating myocardium: an incomplete adaptation to ischemia. Circula-tion 96:2920–2931, 1997.
Elsasser, A., M. Schlepper, R. Zimmermann, K. D. Meuller, R. Strasser, W. P. Kleovekorn, and J. Schaper. The extracel-lular matrix in hibernating myocardium-a significant factor causing structural defects and cardiac dysfunction. Mol. Cell. Biochem. 186:147–158, 1998.
Feigl, E., G. Neat, and A. Huang. Interrelations between coronary artery pressure, myocardial metabolism and coro-nary blood flow. J. Mol. Cell. Cardiol. 22:375–390, 1990.
Flameng, W., R. Suy, F. Schwarz, M. Borgers, J. Piessens, F. Thone, H. Van Ermen, and H. De Geest. Ultrastructural cor-relates of left ventricular contraction abnormalities in patients with chronic ischemic heart disease: determinants of revers-ible segmental asynergy post-revascularization surgery. Am. Heart J. 102:846–857, 1981.
Flameng, W. J., B. Shivalkar, B. Spiessens, A. Maes, J. Nuyts, J. VanHaecke, and L. Mortelmans. PET scan predicts recovery of left ventricular function after coronary artery bypass operation. Ann. of Thoracic Surg. 64:1694–701, 1997.
Fragasso, G., S. Chierchia, G. Lucignani, C. Landoni, A. Conversano, M. Gilardi, F. Colombo, C. Rossetti, and F. Fazio. Time dependence of residual tissue viability after myocardial infarction assessed by [18F] fluorodeoxyglucose and positron emission tomography. Am. J. Cardiol. 72:131G–139G, 1993.
Holmberg, S., W. Serzysko, and E. Varnauskas. Coronary circulation during heavy exercise in control subjects and pa-tients with coronary heart disease. Acta Med. Scand., Suppl. 190:465–480, 1971.
Hutchins, G., M. Schwaiger, K. Rosenspire, J. Krivokapich, H. Schelbert, and D. Kuhl. Noninvasive quantification of regional blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging. J. Am. Coll. Cardiol. 15:1032–1042, 1990.
Keul, J., E. Doll, H. Steim, H. Homburger, H. Kern, and H. Reindell. Uber den Stoffwechsel des menschlichen Herzens. I. Substratversorgung des gesunden Herzens in Ruhe, wa¨hr-end und nach ko¨ rperlicher Arbeit. Pfluegers Arch. Gesamte Physiol. Menschen Tiere 282:1–27, 1965.
Krivokapich, J., S. Huang, and H. Schelbert. Response of absolute myocardial blood flow to dobutamine assessed with nitrogen-13 ammonia and dynamic positron emission tomog-raphy. J. Am. Coll. Cardiol. 17:379A, 1991.
Krivokapich, J., S. C. Huang, and H. R. Schelbert. Assess-ment of the effects of dobutamine on myocardial blood flow and oxidative metabolism in normal human subjects using nitrogen-13 ammonia and carbon-11 acetate. Am. J. Cardiol. 71:1351–1356, 1993.
Krivokapich, J., G. T. Smith, S. C. Huang, E. J. Hoffman, O. Ratib, M. E. Phelps, and H. R. Schelbert. N-13 ammonia myocardial imaging at rest and with exercise in normal vol-unteers: Quantification of absolute myocardial perfusion with dynamic positron emission tomography. Circulation 80:1328–1337, 1989.
Lim, H., J. A. Fallavollita, R. Hard, C. W. Kerr, and J. M. Canty, Jr. Profound apoptosis-mediated regional myocyte loss and compensatory hypertrophy in pigs with hibernating myocardium. Circulation 100:2380–2386, 1999.
Lopaschuk, G., and W. Stanley. Glucose metabolism in the ischemic heart. Circulation 95:313–315, 1997.
Maes, A., W. Flameng, J. Nuyts, M. Borgers, B. Shivalkar, J. Ausma, G. Bormans, C. Schiepers, M. De Roo, and L. Mor-telmans. Histological alterations in chronically hypoperfused myocardium. Correlation with PET findings. Circulation 90:735–745, 1994.
Ng, C. K., S. C. Huang, H. R. Schelbert, and D. B. Buxton. Validation of a model for 1-11C acetate as a tracer of cardiac oxidative metabolism. Am. J. Physiol. 266:H1304–H1315, 1994.
Nuutila, P., V. A. Koivisto, J. Knuuti, U. Ruotsalainen, M. Tereas, M. Haaparanta, J. Bergman, O. Solin, L. M. Voipio– Pulkki, U. Wegelius, and et al. Glucose-free fatty acid cycle operates in human heart and skeletal muscle in vivo. J. Clin. Invest. 89:1767–1774, 1992.
Opie, L. H. The Heart-Physiology and Metabolism. New York: Raven Press, 1991.
Pagano, D., J. N. Townend, W. A. Littler, R. Horton, P. G. Camici, and R. S. Bonser. Coronary artery bypass surgery as treatment for ischemic heart failure: the predictive value of viability assessment with quantitative positron emission to-mography for symptomatic and functional outcome. J. Tho-rac. Cardiovasc. Surg. 115:791–799, 1998.
Phelps, M. E., E. J. Hoffman, C. E. Selin, S. C. Huang, G. Robinson, N. MacDonald, H. Schelbert, and D. E. Kuhl. Investigation of [18F]2-fluoro-2-deoxyglucose for the mea-sure of myocardial glucose metabolism. J. Nucl. Med. 19:1311–1319, 1978.
Rahimtoola, S. H. The hibernating myocardium. Am. Heart J. 117:211–221, 1989.
Randle, P. J., and P. K. Tubbs. Carbohydrate and fatty acid metabolism. In: Handbook of Physiology, Section 2: The Cardiovascular System, edited by R. M. Berne, N. Sperelakis, and S. R. Geiger. Bethesda: The American Physiological Society, 1979 pp. 805–844.
Rubin, P. J., D. S. Lee, V. G. Daavila-Romaan, E. M. Gelt-man, K. B. Schechtman, S. R. Bergmann, and R. J. Gropler. Superiority of C-11 acetate compared with F-18 fluorodeoxy-glucose in predicting myocardial functional recovery by pos-itron emission tomography in patients with acute myocardial infarction. Am. J. Cardiol. 78:1230–1235, 1996.
Schelbert, H. R., E. Henze, H. Sochor, R. G. Grossman, S. C. Huang, J. R. Barrio, M. Schwaiger, and M. E. Phelps. Effects of substrate availability on myocardial C-11 palmitate kinet-ics by positron emission tomography in normal subjects and patients with ventricular dysfunction. Am. Heart J. 111:1055–1064, 1986.
Scho¨ der, H., R. Campisi, T. Ohtake, D. Moon, C. Hoh, J. Czernin, and H. Schelbert. Blood Flow-Metabolism Imaging with Positron Emission Tomography in Patients with Diabe-tes Mellitus for the Assessment of Reversible left Ventricular Contractile Dysfunction. J. Am. Coll. Cardiol. 33:1328–1337, 1999.
Schwaiger, M., D. Sun, G. Deeb, N. Nguyen, F. Haas, F. Sebening, and B. FC. Expression of myocardial glucose transporter (GLUT) mRNAs in patients with advanced coro-nary artery disease (CAD). Circulation 90:I–113, 1994.
Schwarz, E., F. Schoendube, S. Kostin, N. Schmiedtke, G. Schulz, U. Buell, B. Messmer, J. Morrison, P. Hanrath, and J. vom Dahl. Prolonged myocardial hibernation exacerbates car-diomyocyte degeneration and impairs recovery of function after revascularization. J. Am. Coll. Cardiol. 31:1018–1026, 1998.
Schwarz, E. R., J. Schaper, J. vom Dahl, C. Altehoefer, B. Grohmann, F. Schoendube, F. H. Sheehan, R. Uebis, U. Buell, B. J. Messmer, W. Schaper, and P. Hanrath. Myocyte degeneration and cell death in hibernating human myocar-dium. J. Am. Coll. Cardiol. 27:1577–1585, 1996.
Sun, K., K. Chen, S.-C. Huang, D. Buxton, H. Hansen, A. Kim, S. Siegel, Y. Choi, P. Mu¨ ller, M. Phelps, and H. Schel-bert. Compartment model for measuring myocardial oxygen consumption using [1-11 C] acetate. J. Nucl. Med. 38:459–466, 1997.
Sun, K., J. Czernin, J. Krivokapich, M. Bottcher, Y. K. Lau, M. Chen, G. Maurer, and H. R. Schelbert. Wall motion and flow response to low dose dobutamine in apparently normal myocardium of multivessel CAD patients. J. Nucl. Med.:35, 1994.
Tillisch, J., R. Brunken, R. Marshall, M. Schwaiger, M. Man-delkern, M. Phelps, and H. R. Schelbert. Reversibility of cardiac wall motion abnormalities predicted by positron to-mography. N. Engl. J. Med. 314:884–888, 1986.
Young, L., Y. Renfu, R. Russell, X. Hu, M. Caplan, J. Ren, G. Shulman, and A. Sinusas. Low-flow ischemia leads to translocation of canine heart GLUT-4 and GLUT-1 glucose transporters to the sarcolemma in vivo. Circulation 95:415–422, 1997.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schelbert, H.R. PET Contributions to Understanding Normal and Abnormal Cardiac Perfusion and Metabolism. Annals of Biomedical Engineering 28, 922–929 (2000). https://doi.org/10.1114/1.1310216
Issue Date:
DOI: https://doi.org/10.1114/1.1310216